SCHEMBL6664110

SCHEMBL6664110

CC(=O)Nc1ccc(C=CCCN(C)C(=O)OC(C)(C)C)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR3 P25089 1/20 0.37
FPR2 P25090 1/20 0.37
AAK1 Q2M2I8 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
NPR3 P17342 4/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C8 P10632 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDK2 Q15119 1/20 0.34
TRPV1 Q8NER1 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GABRA5 P31644 1/20 0.33
ALK Q9UM73 1/20 0.33
CCNB2 O95067 1/20 0.33
CCNE2 O96020 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663166 0.80 AAK1 (0.46) FPR3FPR2AAK1PDK2KDM4E
SCHEMBL6664107 0.80 AKT1 (0.33) FPR3FPR2AAK1PDK2CCNB2
SCHEMBL6658560 0.78 AAK1 (0.33) AAK1PDK2
SCHEMBL6664102 0.74 MEN1 (0.40) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL24756448 0.74 AAK1 (0.43) FPR3FPR2AAK1NPSR1NPR3
SCHEMBL7099269 0.70 TBXAS1 (0.49) CYP1A2CYP2C9CYP2C19MEN1LMNA
SCHEMBL7099273 0.70 TBXAS1 (0.49) CYP1A2CYP2C9CYP2C19MEN1LMNA
SCHEMBL8429670 0.70 TRPV1 (0.36) AAK1NPSR1NPR3CYP1A2CYP3A4
SCHEMBL12678593 0.68 SMN1; SMN2 (0.46) CYP1A2CYP3A4CYP2C19MEN1LMNA
SCHEMBL20334815 0.67 HDAC6 (0.39) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973743-B1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS TARGACEPT INC (US) 2004-08-25 EP disclosed
US-6531606-B1 Nicotinic compound: N-methyl-4-(3-(5-phenylpyridin)yl)-3-buten-1-amine; capable of affecting nicotinic chlorinergic receptors TARGACEPT, INC. 2003-03-11 US disclosed
US-6274606-B1 ADMINISTERING COMPOUNDS SUCH AS (E)-N-METHYL-4-(3-(5-ISO PROPOXYPYRIDIN)YL)-3-BUTEN-1-AMINE TO TREAT PARKINSON'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT DISORDER, SCHIZOPHRENIA, AND ALZHEIMER'S DISEASE TARGACEPT, INC. 2001-08-14 US disclosed